Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-03
DOI
10.3389/fonc.2020.00435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
- (2019) Germana Castelli et al. Cancers
- Mechanisms of drug resistance in acute myeloid leukemia
- (2019) Jing Zhang et al. OncoTargets and Therapy
- New drugs creating new challenges in acute myeloid leukemia
- (2019) Ing S. Tiong et al. GENES CHROMOSOMES & CANCER
- Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
- (2019) Monica Neagu et al. Frontiers in Oncology
- Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
- (2019) Irène Baccelli et al. CANCER CELL
- In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
- (2019) Remzi Celebi et al. Scientific Reports
- Metabolic Plasticity of Acute Myeloid Leukemia
- (2019) Kreitz et al. Cells
- Oxidative phosphorylation inhibition induces anticancerous changes in therapy‐resistant–acute myeloid leukemia patient cells
- (2019) Aida Vitkevičienė et al. MOLECULAR CARCINOGENESIS
- A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs
- (2019) Svetlana B. Panina et al. Cell Death & Disease
- Metabolic dependencies and vulnerabilities in leukemia
- (2019) Marissa Rashkovan et al. GENES & DEVELOPMENT
- The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
- (2019) Sillar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
- (2019) Brian A. Jonas et al. LEUKEMIA
- Can we selectively target AML stem cells?
- (2019) Craig T. Jordan BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
- (2018) Timothy S. Pardee et al. CLINICAL CANCER RESEARCH
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function
- (2018) Ming Zhuo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
- (2018) Peter Paschka et al. LEUKEMIA
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells
- (2018) Hima V. Vangapandu et al. Oncotarget
- Cancer Stem Cell Metabolism and Potential Therapeutic Targets
- (2018) Vusala Snyder et al. Frontiers in Oncology
- Targeting mitochondria in cancer: current concepts and immunotherapy approaches
- (2018) Sergey Pustylnikov et al. Translational Research
- Oxidative degradation of polyamines by serum supplement causes cytotoxicity on cultured cells
- (2018) Linlin Wang et al. Scientific Reports
- Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia
- (2018) Sharon Wu et al. Scientific Reports
- Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
- (2018) Gantumur Battogtokh et al. Frontiers in Pharmacology
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation
- (2017) Wo-Lin Hou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
- (2017) Kyuho Han et al. NATURE BIOTECHNOLOGY
- Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
- (2017) Stephen E. Kurtz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation
- (2017) Sabrina Heinz et al. Scientific Reports
- Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities
- (2016) Elena de Blas et al. Cancer Cell International
- Oxidative stress and hypoxia in normal and leukemic stem cells
- (2016) Ugo Testa et al. EXPERIMENTAL HEMATOLOGY
- Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
- (2016) Samy A. F. Morad et al. JOURNAL OF LIPID RESEARCH
- An update of current treatments for adult acute myeloid leukemia
- (2015) H. Dombret et al. BLOOD
- Targeting respiratory complex I to prevent the Warburg effect
- (2015) Renaud Vatrinet et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mitochondrial dependency in progression of acute myeloid leukemia
- (2015) Nandini Pal Basak et al. MITOCHONDRION
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia
- (2013) Neerav Shukla et al. PEDIATRIC BLOOD & CANCER
- Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models
- (2012) Nian Xiong et al. CRITICAL REVIEWS IN TOXICOLOGY
- Influence of fetal bovine serum on cytotoxic and genotoxic effects of lectins in MCF-7 cells
- (2011) Glaucia Veríssimo Faheina-Martins et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin
- (2011) Lauren J. Akers et al. LEUKEMIA RESEARCH
- Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
- (2010) Caroline Jose et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- The pharmacological NFκB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation
- (2009) Alfeu Zanotto-Filho et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now